Targeting Aurora kinase A and JAK2 prevents GVHD while maintaining Treg and antitumor CTL function.
about
Azacytidine prevents experimental xenogeneic graft-versus-host disease without abrogating graft-versus-leukemia effects.Targeting JAK2 reduces GVHD and xenograft rejection through regulation of T cell differentiation.Lymphocytes in Placental Tissues: Immune Regulation and Translational Possibilities for Immunotherapy.Tumor-infiltrating neutrophils predict prognosis and adjuvant chemotherapeutic benefit in patients with biliary cancer.
P2860
Targeting Aurora kinase A and JAK2 prevents GVHD while maintaining Treg and antitumor CTL function.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Targeting Aurora kinase A and ...... eg and antitumor CTL function.
@en
Targeting Aurora kinase A and ...... eg and antitumor CTL function.
@nl
type
label
Targeting Aurora kinase A and ...... eg and antitumor CTL function.
@en
Targeting Aurora kinase A and ...... eg and antitumor CTL function.
@nl
prefLabel
Targeting Aurora kinase A and ...... eg and antitumor CTL function.
@en
Targeting Aurora kinase A and ...... eg and antitumor CTL function.
@nl
P2093
P2860
P1476
Targeting Aurora kinase A and ...... eg and antitumor CTL function.
@en
P2093
Anandharaman Veerapathran
Brian C Betts
Christopher L Cubitt
Claudio Anasetti
Harshani R Lawrence
Joseph Pidala
Kelly Walton
Nicholas J Lawrence
Pedro Horna
P2860
P356
10.1126/SCITRANSLMED.AAI8269
P407
P577
2017-01-01T00:00:00Z